234 related articles for article (PubMed ID: 33482769)
1. Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
Palmerini E; Seeger LL; Gambarotti M; Righi A; Reichardt P; Bukata S; Blay JY; Dai T; Jandial D; Picci P
BMC Cancer; 2021 Jan; 21(1):89. PubMed ID: 33482769
[TBL] [Abstract][Full Text] [Related]
2. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
[TBL] [Abstract][Full Text] [Related]
3. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
Arefpour A; Shafieesabet M; Chehrassan M; Ahmadzadehnanva A; Ghandhari H
Musculoskelet Surg; 2024 Mar; 108(1):93-98. PubMed ID: 37940782
[TBL] [Abstract][Full Text] [Related]
4. Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update.
Tsukamoto S; Mavrogenis AF; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Errani C
Curr Oncol; 2024 Apr; 31(4):2112-2132. PubMed ID: 38668060
[TBL] [Abstract][Full Text] [Related]
5. Denosumab Induces Neoplastic Stromal Cell Apoptosis
Chen X; Ye F; He H; Chen G; Chen Z; Ye E; He B; Yang Y; Zhang J
Curr Cancer Drug Targets; 2024; 24(5):565-578. PubMed ID: 37961860
[TBL] [Abstract][Full Text] [Related]
6. The Evaluation and Management of Lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognoses of six patients with multicentric giant cell tumor of the bone.
Liu C; Tang Y; Li M; Jiao Q; Zhang H; Yang Q; Yao W
Oncotarget; 2016 Dec; 7(50):83795-83805. PubMed ID: 27823978
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1.
Adachi Y; Noguchi R; Yoshimatsu Y; Sin Y; Osaki J; Ono T; Iwata S; Akiyama T; Tsuchiya R; Toda Y; Ishihara S; Ogura K; Kobayashi E; Kojima N; Yoshida A; Yokoo H; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):874-885. PubMed ID: 38466561
[TBL] [Abstract][Full Text] [Related]
10. Denosumab for an inoperable giant cell tumour of the ischial bone.
Paul AG; See LP; Ohn MH; Ohn KM
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38110341
[TBL] [Abstract][Full Text] [Related]
11. The Role of Denosumab in the Treatment of Primary Tumors of Bone.
Wessel LE; Strike SA; Singh A; Bernthal NM; Athanasian EA
J Hand Surg Am; 2023 Sep; 48(9):923-930. PubMed ID: 37032292
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of Denosumab in Middle Eastern Patients With Giant Cell Tumor of the Bone: A Single-Center, Retrospective Study.
Elshenawy M; Arabi TZ; Ateya HA; Elhassan T; Ali SS; Othman RK; Alkhatib R; Elshentenawy A; Badran A
Cureus; 2024 Apr; 16(4):e58292. PubMed ID: 38752067
[TBL] [Abstract][Full Text] [Related]
13. Denosumab treatment for progressive Enneking stage II cervical giant-cell tumor conservatively.
Tan Y; Zhang S; Zhang J; Huang T; Li X; Zhou X; Zhang J
Funct Integr Genomics; 2023 Mar; 23(1):76. PubMed ID: 36867323
[TBL] [Abstract][Full Text] [Related]
14. Human Chorionic Gonadotropin Regulates the Smad Signaling Pathway by Antagonizing TGF-β in Giant Cell Tumor of Bone.
Xu T; Xu S; Ma G; Chang J; Zhang C; Zhou P; Wang C; Xu P; Yang J; Hu Y; Wu Y
Recent Pat Anticancer Drug Discov; 2024; 19(2):188-198. PubMed ID: 38214358
[TBL] [Abstract][Full Text] [Related]
15. Histological and immunohistochemical analyses of osteoclast maturation in giant cell tumor of bone.
Agawa R; Kato I; Kawabata Y; Takeyama M; Fujii S
Pathol Res Pract; 2024 Feb; 254():155128. PubMed ID: 38244437
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of denosumab treatment for lung metastasis secondary to proximal humerus chondroblastoma.
Samargandi R; Bernard M; Miquelestorena-Standley E; Nail LRL
Saudi Med J; 2024 Jun; 45(6):633-638. PubMed ID: 38830665
[TBL] [Abstract][Full Text] [Related]
17. Denosumab in Patients with Giant Cell Tumor and Its Recurrence: A Systematic Review.
Jamshidi K; Gharehdaghi M; Hajialiloo SS; Mirkazemi M; Ghaffarzadehgan K; Izanloo A
Arch Bone Jt Surg; 2018 Jul; 6(4):260-268. PubMed ID: 30175172
[TBL] [Abstract][Full Text] [Related]
18. Central giant cell granuloma: Off-label treatment with Denosumab in a patient with Noonan syndrome.
Amorós CM; Bascones AE; Leone RC; De la Sen Corcuera Ó; Barone S; De Pedro Marina M
J Stomatol Oral Maxillofac Surg; 2024 Feb; 125(1):101640. PubMed ID: 37729965
[TBL] [Abstract][Full Text] [Related]
19. Giant cell tumor of bone at distal radius suffered more soft tissue recurrence and ultrasonography is effective to detect the soft tissue recurrence.
Cui L; Sun Y; Jin T; Fan D; Liu W
Discov Oncol; 2024 Apr; 15(1):103. PubMed ID: 38573423
[TBL] [Abstract][Full Text] [Related]
20. Giant cell tumor of bone: a neoplasm or a reactive condition?
Haque AU; Moatasim A
Int J Clin Exp Pathol; 2008 Jan; 1(6):489-501. PubMed ID: 18787633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
